SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-17-000081
Filing Date
2017-08-14
Accepted
2017-08-14 16:16:29
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-063017x10q.htm 10-Q 647657
2 EXHIBIT 10.1 ebio-063017101.htm EX-10.1 12977
3 EXHIBIT 31.1 ebio-063017x311.htm EX-31.1 12084
4 EXHIBIT 31.2 ebio-063017x312.htm EX-31.2 11950
5 EXHIBIT 32.1 ebio-063017x321.htm EX-32.1 7015
12 ebiologoa21.jpg GRAPHIC 89522
  Complete submission text file 0001485003-17-000081.txt   3449117

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ebio-20170630.xml EX-101.INS 662225
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20170630.xsd EX-101.SCH 23373
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20170630_cal.xml EX-101.CAL 58340
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20170630_def.xml EX-101.DEF 97019
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20170630_lab.xml EX-101.LAB 360459
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20170630_pre.xml EX-101.PRE 208012
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 171030326
SIC: 2834 Pharmaceutical Preparations